Patient & Visitor InformationContact Us
  • Preservation Trial

  •   Contact:
    Rhode Island Hospital
    Cardiac Projects Office 

    Rhode Island Hospital is participating in Ikaria’s PRESERVATION I clinical trial. PRESERVATION I is a multi-national, placebo-controlled trial investigating the safety and efficacy of the Bioabsorbable Cardiac Matrix device, or BCM, which is being developed for the prevention of ventricular remodeling and subsequent congestive heart failure following acute myocardial infarction (heart attack). There are currently no FDA-approved treatments to prevent cardiac remodeling following a heart attack. For more information about this trial, visit